Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Tbilisi Pediatric Priva… | Healthcare Services | 35.0% | 92nd pct | 268 |
| Kardiologiuri Klinika G… | Healthcare Services | 13.9% | 62nd pct | 268 |
| Neprologiis Ganvitarebi… | Healthcare Services | 4.0% | 32nd pct | 268 |
| Acharis A.r. Onkologiis… | Healthcare Services | — | no FY data | 268 |
| Mtskheta Medical Center | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 3 of 5 peers filed FY2024. Switch to FY2018 (5 of 5).
| Ratio — FY 2024 | Tbilisi Pediatric Priva… | Neprologiis Ganvitarebi… | Kardiologiuri Klinika G… | Acharis A.r. Onkologiis… | Mtskheta Medical Center |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 89.7% | 27.6% | 82.0% | — | — |
| EBITDA Margin | 35.0% | 4.0% | 13.9% | — | — |
| EBITDAR | 2,151 | 277 | 830 | — | — |
| EBITDAR Margin | 35.0% | 4.6% | 14.5% | — | — |
| EBIT Margin | 28.5% | 0.8% | 8.1% | — | — |
| Net Profit Margin | 30.4% | 0.8% | 8.5% | — | — |
| Operating Expense % of Sales | 54.7% | 23.6% | 68.1% | — | — |
| Returns | |||||
| Return on Assets (ROA) | 21.5% | 1.0% | 2.6% | — | — |
| Return on Equity (ROE) | 23.1% | 1.4% | 2.8% | — | — |
| ROIC [EBIT / Invested Capital] | 22.9% | 1.5% | 2.6% | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | 0.0% | 2.4% | — | — |
| Debt-to-Equity | 0.00x | 0.00x | 0.03x | — | — |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.57x | — | — |
| Equity-to-Assets | 93.0% | 70.5% | 92.5% | — | — |
| Net Debt | -445 | -62 | 431 | — | — |
| Cash & Equivalents | 445 | 62 | 27 | — | — |
| Total Debt | N/A | N/A | 458 | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 2.86x | 1.48x | 1.25x | — | — |
| Quick Ratio | 2.51x | 1.48x | 1.25x | — | — |
| Cash Ratio | 0.73x | 0.05x | 0.02x | — | — |
| Total Current Assets | 1,752 | 1,883 | 1,476 | — | — |
| Total Current Liabilities | 613 | 1,270 | 1,180 | — | — |
| Inventory | 211 | N/A | N/A | — | — |
| Trade Receivables | 1,057 | 1,883 | 894 | — | — |
| Trade Payables | 380 | 1,207 | 795 | — | — |
| Net Working Capital | 1,138 | 613 | 297 | — | — |
| Net Working Capital % of Revenue | 18.5% | 10.3% | 5.2% | — | — |
| Trade Working Capital | 888 | 676 | 99 | — | — |
| Trade Working Capital % of Revenue | 14.5% | 11.3% | 1.7% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | 2.99x | N/A | N/A | — | — |
| Days Inventory Outstanding (DIO) | 122.0 | N/A | N/A | — | — |
| Receivables Turnover | 5.81x | 3.16x | 6.42x | — | — |
| Days Sales Outstanding (DSO) | 62.8 | 115.4 | 56.8 | — | — |
| Payables Turnover | 1.66x | 3.57x | 1.30x | — | — |
| Days Payable Outstanding (DPO) | 219.6 | 102.2 | 280.2 | — | — |
| Cash Conversion Cycle | -34.8 days | 13.2 days | -223.4 days | — | — |
| Asset Turnover | 0.71x | 1.19x | 0.30x | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | -511 | 125 | 749 | — | — |
| Free Cash Flow (OCF − Capex proxy) | -554 | 3 | 399 | — | — |
| Cash Conversion (OCF / EBITDA) | -23.8% | 52.0% | 94.0% | — | — |
| Dividends Declared | 3,399 | N/A | N/A | — | — |
| Dividend Payout Ratio | 181.8% | N/A | N/A | — | — |